Evidence map›Paper›PMID 36430280›Full record

ArticleInternational journal of molecular sciences2022

Effect of Goreisan, a Japanese Traditional Medicine, on Cortical Spreading Depolarization in Mice.

Chisato Iba, Miyuki Unekawa, Yoshikane Izawa, Jin Nakahara, Tsubasa Takizawa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chisato IbaDepartment of Neurology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Miyuki UnekawaDepartment of Neurology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yoshikane IzawaDepartment of Neurology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0001-9416-4660
Jin NakaharaDepartment of Neurology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Tsubasa TakizawaDepartment of Neurology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0003-2605-7200
Keio University · JP

Funding

Keio University Program for the Advancement of Next Generation Research Projects N/ATsumura & Co. N/A
6 · The paper itself

Abstract

Goreisan, a traditional Japanese Kampo medicine, is often used to treat headaches, including migraines; however, the underlying mechanisms remain unknown. Therefore, we investigated whether chronic treatment with Goreisan affects cortical spreading depolarization (CSD) in migraines. CSD susceptibility was assessed in male and female C57BL/6 mice by comparing CSD threshold, propagation velocity, and CSD frequency between animals treated with Goreisan for approximately 3 weeks and the corresponding controls with a potassium-induced CSD model. No significant differences were observed in CSD susceptibility between mice that were chronically treated with Goreisan and the control mice. Additionally, no significant differences were observed in other physiological parameters, including body weight, blood gases, and blood pressure. CSD susceptibility was not affected by chronic treatment with Goreisan, which suggests that the drug treats headaches via mechanisms that do not involve CSD modulation.

Indexed as

Cortical Spreading DepressionMigraine DisordersAnimalsDrugs, Chinese HerbalFemaleHeadacheJapanMaleMedicine, TraditionalMiceMice, Inbred C57BLDrugs, Chinese Herbaloryeongsancortical spreading depolarizationGoreisanKampo medicinemigraine

Identifiers

PMID36430280
PMCPMC9694318
OpenAlexW4308876472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.